Cyclerion Therapeutics Inc
CYCN1.100USD
+0.020+1.85%
終値 02/06, 16:00（ET）15分遅れの株価
4.06M時価総額
損失額直近12ヶ月PER
詳細情報 Cyclerion Therapeutics Inc 企業名
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Incの企業情報
企業コードCYCN
会社名Cyclerion Therapeutics Inc
上場日Mar 18, 2019
最高経営責任者「CEO」Graul (Regina M)
従業員数1
証券種類Ordinary Share
決算期末Mar 18
本社所在地301 Binney Street
都市CAMBRIDGE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号02142
電話番号16176217722
ウェブサイトhttps://www.cyclerion.com/
企業コードCYCN
上場日Mar 18, 2019
最高経営責任者「CEO」Graul (Regina M)
Cyclerion Therapeutics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
+1650.00%
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
+1650.00%
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sat, Jan 31
更新時刻: Sat, Jan 31
株主統計
種類
株主統計
株主統計
比率
Hecht (Peter M)
14.25%
J. Wood Capital Advisors LLC
4.63%
American Endowment Foundation
3.39%
Invus Public Equities Advisors, LLC
2.96%
Graul (Regina Margaret)
1.42%
他の
73.35%
株主統計
株主統計
比率
Hecht (Peter M)
14.25%
J. Wood Capital Advisors LLC
4.63%
American Endowment Foundation
3.39%
Invus Public Equities Advisors, LLC
2.96%
Graul (Regina Margaret)
1.42%
他の
73.35%
種類
株主統計
比率
Individual Investor
18.74%
Corporation
8.02%
Investment Advisor
5.71%
Investment Advisor/Hedge Fund
0.95%
Hedge Fund
0.40%
Research Firm
0.02%
他の
66.15%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
33
277.64K
23.79%
--
2025Q3
36
277.64K
28.05%
-103.98K
2025Q2
36
381.62K
29.96%
-10.58K
2025Q1
53
392.20K
30.91%
-599.93K
2024Q4
57
398.50K
41.58%
-660.57K
2024Q3
62
1.11M
44.54%
-7.58K
2024Q2
66
1.10M
44.98%
-18.58K
2024Q1
76
1.12M
48.61%
-196.27K
2023Q4
83
1.12M
54.12%
-3.34K
2023Q3
98
1.12M
59.61%
-44.82K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Hecht (Peter M)
559.20K
14.25%
--
--
Apr 21, 2025
J. Wood Capital Advisors LLC
181.82K
4.63%
--
--
Aug 01, 2025
American Endowment Foundation
133.03K
3.39%
+133.03K
--
Dec 31, 2024
Invus Public Equities Advisors, LLC
116.16K
2.96%
--
--
Sep 30, 2025
Graul (Regina Margaret)
55.78K
1.42%
-44.52K
-44.39%
Apr 21, 2025
De Souza (Errol B)
50.00K
1.27%
--
--
Apr 21, 2025
DRW Securities, LLC
43.62K
1.11%
+43.62K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
37.16K
0.95%
+4.42K
+13.51%
Sep 30, 2025
Higgins (Michael J)
30.74K
0.78%
+1.65K
+5.67%
Apr 21, 2025
The Vanguard Group, Inc.
23.49K
0.6%
--
--
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Fidelity Nasdaq Composite Index ETF
0%
Fidelity Nasdaq Composite Index ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
日付
配当落ち日
種類
比率
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
